Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 222

1.

CCR6 Defines Memory B Cell Precursors in Mouse and Human Germinal Centers, Revealing Light-Zone Location and Predominant Low Antigen Affinity.

Suan D, Kräutler NJ, Maag JLV, Butt D, Bourne K, Hermes JR, Avery DT, Young C, Statham A, Elliott M, Dinger ME, Basten A, Tangye SG, Brink R.

Immunity. 2017 Dec 19;47(6):1142-1153.e4. doi: 10.1016/j.immuni.2017.11.022.

PMID:
29262350
2.

Differentiation of germinal center B cells into plasma cells is initiated by high-affinity antigen and completed by Tfh cells.

Kräutler NJ, Suan D, Butt D, Bourne K, Hermes JR, Chan TD, Sundling C, Kaplan W, Schofield P, Jackson J, Basten A, Christ D, Brink R.

J Exp Med. 2017 May 1;214(5):1259-1267. doi: 10.1084/jem.20161533. Epub 2017 Mar 31.

3.

FAS Inactivation Releases Unconventional Germinal Center B Cells that Escape Antigen Control and Drive IgE and Autoantibody Production.

Butt D, Chan TD, Bourne K, Hermes JR, Nguyen A, Statham A, O'Reilly LA, Strasser A, Price S, Schofield P, Christ D, Basten A, Ma CS, Tangye SG, Phan TG, Rao VK, Brink R.

Immunity. 2015 May 19;42(5):890-902. doi: 10.1016/j.immuni.2015.04.010. Epub 2015 May 12.

4.

Open letter to the Hon Tony Abbott MP.

McMichael AJ, Leeder SR, Armstrong BK, Basten A, Doherty PC, Douglas RM, Green AC, Nossal GJ, Shearman DJ, Stanley FJ, Vimpani GV, Wodak AD.

Med J Aust. 2014 Sep 1;201(5):252. No abstract available.

PMID:
25163366
5.

A novel pilot study of endometrial stromal cells and immune cell populations in sentinel uterine-draining lymph nodes during the menstrual cycle and in endometriosis.

Berbic M, Ng CH, Black K, Markham R, Russell P, Basten A, Fraser IS, Hey-Cunningham AJ.

Reprod Sci. 2013 Nov;20(11):1339-48. doi: 10.1177/1933719113485298. Epub 2013 May 29.

PMID:
23719712
6.

Elimination of germinal-center-derived self-reactive B cells is governed by the location and concentration of self-antigen.

Chan TD, Wood K, Hermes JR, Butt D, Jolly CJ, Basten A, Brink R.

Immunity. 2012 Nov 16;37(5):893-904. doi: 10.1016/j.immuni.2012.07.017. Epub 2012 Nov 8.

7.

Deletion of cIAP1 and cIAP2 in murine B lymphocytes constitutively activates cell survival pathways and inactivates the germinal center response.

Gardam S, Turner VM, Anderton H, Limaye S, Basten A, Koentgen F, Vaux DL, Silke J, Brink R.

Blood. 2011 Apr 14;117(15):4041-51. doi: 10.1182/blood-2010-10-312793. Epub 2011 Feb 7.

8.

Enhanced responsiveness to T-cell help causes loss of B-lymphocyte tolerance to a β-cell neo-self-antigen in type 1 diabetes prone NOD mice.

Cox SL, Stolp J, Hallahan NL, Counotte J, Zhang W, Serreze DV, Basten A, Silveira PA.

Eur J Immunol. 2010 Dec;40(12):3413-25. doi: 10.1002/eji.201040817. Epub 2010 Nov 11.

9.

B-cell tolerance: mechanisms and implications.

Basten A, Silveira PA.

Curr Opin Immunol. 2010 Oct;22(5):566-74. doi: 10.1016/j.coi.2010.08.001. Epub 2010 Sep 9. Review.

PMID:
20829011
10.

Expression, purification and characterization of recombinant interleukin-21.

Lee CM, McGuire H, Basten A, King C, Christ D.

J Immunol Methods. 2010 Oct 31;362(1-2):185-9. doi: 10.1016/j.jim.2010.08.008. Epub 2010 Aug 25.

PMID:
20800065
11.

The role of B cells in transplantation and immunopathic diseases.

Basten A.

Immune Netw. 2010 Jun;10(3):81-4. doi: 10.4110/in.2010.10.3.81. Epub 2010 Jun 30.

12.

Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice.

Goodnow CC, Crosbie J, Adelstein S, Lavoie TB, Smith-Gill SJ, Brink RA, Pritchard-Briscoe H, Wotherspoon JS, Loblay RH, Raphael K, Trent RJ, Basten A.

J Immunol. 2009 Nov 1;183(9):5442-8. No abstract available.

13.

Antigen affinity controls rapid T-dependent antibody production by driving the expansion rather than the differentiation or extrafollicular migration of early plasmablasts.

Chan TD, Gatto D, Wood K, Camidge T, Basten A, Brink R.

J Immunol. 2009 Sep 1;183(5):3139-49. doi: 10.4049/jimmunol.0901690. Epub 2009 Aug 7.

14.

Guidance of B cells by the orphan G protein-coupled receptor EBI2 shapes humoral immune responses.

Gatto D, Paus D, Basten A, Mackay CR, Brink R.

Immunity. 2009 Aug 21;31(2):259-69. doi: 10.1016/j.immuni.2009.06.016. Epub 2009 Jul 16.

15.

TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor.

Gardam S, Sierro F, Basten A, Mackay F, Brink R.

Immunity. 2008 Mar;28(3):391-401. doi: 10.1016/j.immuni.2008.01.009. Epub 2008 Feb 28.

16.

Special regulatory T-cell review: T-cell dependent suppression revisited.

Basten A, Fazekas de St Groth B.

Immunology. 2008 Jan;123(1):33-9. Review.

17.

The evolution of clinical immunology and allergy in Australia.

Basten A.

Immunol Cell Biol. 2008 Jan;86(1):16-21. Epub 2007 Nov 27. No abstract available.

PMID:
18040282
18.

High affinity germinal center B cells are actively selected into the plasma cell compartment.

Phan TG, Paus D, Chan TD, Turner ML, Nutt SL, Basten A, Brink R.

J Exp Med. 2006 Oct 30;203(11):2419-24. Epub 2006 Oct 9.

19.

Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation.

Paus D, Phan TG, Chan TD, Gardam S, Basten A, Brink R.

J Exp Med. 2006 Apr 17;203(4):1081-91. Epub 2006 Apr 10.

20.

Tumor necrosis factor receptor 2 (TNFR2) signaling is negatively regulated by a novel, carboxyl-terminal TNFR-associated factor 2 (TRAF2)-binding site.

Grech AP, Gardam S, Chan T, Quinn R, Gonzales R, Basten A, Brink R.

J Biol Chem. 2005 Sep 9;280(36):31572-81. Epub 2005 Jul 14.

22.
23.

TRAF2 differentially regulates the canonical and noncanonical pathways of NF-kappaB activation in mature B cells.

Grech AP, Amesbury M, Chan T, Gardam S, Basten A, Brink R.

Immunity. 2004 Nov;21(5):629-42.

24.

Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches.

Thien M, Phan TG, Gardam S, Amesbury M, Basten A, Mackay F, Brink R.

Immunity. 2004 Jun;20(6):785-98.

25.

Clonal cytotoxic T cells in myeloma.

Sze DM, Brown RD, Yuen E, Gibson J, Ho J, Raitakari M, Basten A, Joshua DE, Fazekas de St Groth B.

Leuk Lymphoma. 2003 Oct;44(10):1667-74. Review.

PMID:
14692517
26.

Dermal enhancement: bacterial products on intact skin induce and augment organ-specific autoimmune disease.

Riminton DS, Kandasamy R, Dravec D, Basten A, Baxter AG.

J Immunol. 2004 Jan 1;172(1):302-9.

27.

Reduced switching in SCID B cells is associated with altered somatic mutation of recombined S regions.

Cook AJ, Oganesian L, Harumal P, Basten A, Brink R, Jolly CJ.

J Immunol. 2003 Dec 15;171(12):6556-64.

28.

Prediction of high affinity class I-restricted multiple myeloma idiotype peptide epitopes.

Szea DM, Brown RD, Yang S, Gibson J, Ho J, Fazekas de St Groth B, Basten A, Joshua DE.

Leuk Lymphoma. 2003 Sep;44(9):1557-68.

PMID:
14565660
29.

B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells.

Phan TG, Amesbury M, Gardam S, Crosbie J, Hasbold J, Hodgkin PD, Basten A, Brink R.

J Exp Med. 2003 Apr 7;197(7):845-60. Epub 2003 Mar 31.

30.

Clonal cytotoxic T cells are expanded in myeloma and reside in the CD8(+)CD57(+)CD28(-) compartment.

Sze DM, Giesajtis G, Brown RD, Raitakari M, Gibson J, Ho J, Baxter AG, Fazekas de St Groth B, Basten A, Joshua DE.

Blood. 2001 Nov 1;98(9):2817-27.

31.

Recirculating and marginal zone B cell populations can be established and maintained independently of primary and secondary follicles.

Körner H, Winkler TH, Sedgwick JD, Röllinghoff M, Basten A, Cook MC.

Immunol Cell Biol. 2001 Feb;79(1):54-61.

PMID:
11168624
32.
33.

The Centenary Institute of Cancer Medicine and Cell Biology.

Basten A.

Med J Aust. 1999 Dec 6-20;171(11-12):634-7. No abstract available.

PMID:
10721354
34.

Image of the month. Hereditary angioedema (HAE).

Wong RC, Phan TG, Adelstein S, Basten A.

Gastroenterology. 1999 Mar;116(3):514, 777. No abstract available.

PMID:
10465628
35.

Simvastatin in nephrotic syndrome. Simvastatin in Nephrotic Syndrome Study Group.

Olbricht CJ, Wanner C, Thiery J, Basten A.

Kidney Int Suppl. 1999 Jul;71:S113-6.

PMID:
10412752
36.

Influence of B cell receptor ligation and TCR affinity on T-B collaboration in vitro.

Cook MC, Basten A, Fazekas de St Groth B.

Eur J Immunol. 1998 Dec;28(12):4037-49.

37.

Generation of splenic follicular structure and B cell movement in tumor necrosis factor-deficient mice.

Cook MC, Körner H, Riminton DS, Lemckert FA, Hasbold J, Amesbury M, Hodgkin PD, Cyster JG, Sedgwick JD, Basten A.

J Exp Med. 1998 Oct 19;188(8):1503-10.

38.

Rescue of self-reactive B cells by provision of T cell help in vivo.

Cook MC, Basten A, Fazekas de St Groth B.

Eur J Immunol. 1998 Aug;28(8):2549-58.

39.

A test of lymphoma induction by long-term exposure of E mu-Pim1 transgenic mice to 50 Hz magnetic fields.

Harris AW, Basten A, Gebski V, Noonan D, Finnie J, Bath ML, Bangay MJ, Repacholi MH.

Radiat Res. 1998 Mar;149(3):300-7.

PMID:
9496894
40.

B cell life span: a review.

Fulcher DA, Basten A.

Immunol Cell Biol. 1997 Oct;75(5):446-55. Review.

PMID:
9429891
42.

Evaluation of antisense inhibition in a B cell model.

McCall MN, Kuchel MG, Basten A.

Biochem Mol Biol Int. 1997 Jun;42(1):45-56.

PMID:
9192084
43.

Influences on the lifespan of B cell subpopulations defined by different phenotypes.

Fulcher DA, Basten A.

Eur J Immunol. 1997 May;27(5):1188-99.

PMID:
9174610
44.

Lymphomas in E mu-Pim1 transgenic mice exposed to pulsed 900 MHZ electromagnetic fields.

Repacholi MH, Basten A, Gebski V, Noonan D, Finnie J, Harris AW.

Radiat Res. 1997 May;147(5):631-40.

PMID:
9146709
46.
47.

Role of dendritic cells in induction of tolerance and immunity in vivo.

Fazekas de St Groth B, Cook MC, Smith AL, Wikstrom ME, Basten A.

Adv Exp Med Biol. 1997;417:255-63. No abstract available.

PMID:
9286370
48.
49.

B-cell activation and tolerance. Introduction.

Basten A.

Int Rev Immunol. 1997;15(1-2):1-4. No abstract available.

PMID:
9178069
50.

Australia's fourth Nobel laureate for medicine.

Basten A.

Med J Aust. 1996 Dec 2-16;165(11-12):656-7. No abstract available.

PMID:
8985451

Supplemental Content

Loading ...
Support Center